Using advanced MRI technology to improve prostate cancer detection
Computer Aided Diagnostic System for Prostate Cancer Detection Using Quantitative Multiparametric MRI
This study is testing a new computer tool that uses special MRI scans to better spot prostate cancer and show how aggressive it is, helping doctors make smarter treatment choices while reducing unnecessary tests and treatments for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-10919247 on NIH RePORTER |
What this research studies
This research focuses on enhancing the detection of prostate cancer through a computer-aided diagnostic system that utilizes quantitative multiparametric MRI (mpMRI). By creating a Composite Biomarker Score (CBS) map, the study aims to provide a more accurate visual representation of prostate cancer aggressiveness, which can help guide treatment decisions. The approach seeks to reduce the risks of overdiagnosis and overtreatment by improving the sensitivity and specificity of cancer detection. Patients may benefit from a more tailored and less invasive management strategy for their prostate cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are men who are at risk for prostate cancer or have been diagnosed with prostate cancer and are considering treatment options.
Not a fit: Patients with non-cancerous prostate conditions or those who have already undergone definitive treatment for prostate cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate prostate cancer diagnoses and better treatment options for patients.
How similar studies have performed: Previous research has shown promise in using advanced imaging techniques for cancer detection, indicating that this approach could be a significant advancement in prostate cancer diagnostics.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Metzger, Gregory John — University of Minnesota
- Study coordinator: Metzger, Gregory John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.